| accession | Q5QGZ9 |
| Source | DNA sequence encoding Human CLEC12A/MICL/CLL-1 including a N-hFc-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology. |
| Molecular weight | Recombinant Human CLEC12A/MICL/CLL-1 is a protein consisting of amino acid residues [His65-Ala265] ,The protein has a predicted MW of 51.7 kDa. Due to glycosylation, the protein migrates to 67-70 kDa based on Tris-Bis PAGE result.. |
| Purity | >95%, as determined by SDS-PAGE and HPLC |
| Biological Activity | see methods section |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg). |
| Presentation | Recombinant Human CLEC12A/MICL/CLL-1 was lyophilized from 0.2 µm filtered PBS solution pH7.4 |
| Reconstitution | Centrifuge vial to ensure maximal product extraction, recommended:20sec, 5K RPM |
| Storage | The lyophilized protein is stable for at least 2 years from date of receipt at -20° C. |
| Usage | This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
Methods
Biotinylated Human CLEC12A/MICL/CLL-1 Protein Tris-Bis PAGE
|
Biotinylated Human CLEC12A/MICL/CLL-1 Protein SEC-HPLC
|
Biotinylated Human CLEC12A/MICL/CLL-1 Protein ELISA Data
|
